Why is Binding CD64+ Important When Discussing IL23 Directed Therapy

Join Heather Mambretti, a member of RhAPP, as she discusses the significance of CD64 positive binding in IL-23 directed therapy. In this video, Heather explains how targeting CD64 positive cells enhances the specificity and efficacy of IL-23 directed treatments, such as guselkumab, by delivering therapeutic agents directly to sites of inflammation.